<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03886337</url>
  </required_header>
  <id_info>
    <org_study_id>201901773</org_study_id>
    <nct_id>NCT03886337</nct_id>
  </id_info>
  <brief_title>Impact of Germicidal Light</brief_title>
  <official_title>Evaluation of the Impact of Germicidal Light on Intraoperative S. Aureus Exposure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Iowa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kenall Manufacturing</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Iowa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Visible light at 405nm has been shown to be germicidal. The hypothesis is that use of this
      light (Indigo-Clean Lights) in operating rooms will reduce S. aureus transmission occurring
      within and between patients and reduce surgical site infections (SSIs). Investigators will
      evaluate a case-control study where patients undergoing surgery with the lights are matched
      with patients undergoing surgery without germicidal lights.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Operating room S. aureus exposure has been directly linked to postoperative infections and is
      therefore an important target for infection prevention. Visible light at 405nm has been shown
      to be germicidal. Investigators plan to install ambient, germicidal lighting (Indigo-Clean
      Lights) that uses this wavelength in 4 operating rooms. Patients will undergo surgery
      according to usual practice. Investigators will conduct a case-control study where patients
      undergoing surgery with the lights are matched with patients undergoing surgery without the
      germicidal lights. Patients will be matched by procedure then case duration then American
      Society of Anesthesiologists (ASA) physical status health classification. These patients will
      undergo infection surveillance. Infection surveillance will involve use of National
      Healthcare Safety Network (NHSN) checklists applied to patients who are positive for one or
      more of the initial screening criteria (elevated white blood cell count, fever (&gt;38.4 degrees
      Celsius), office note documentation of infection, positive culture (sputum, blood, urine,
      wound, other body fluid), or anti-infective order within the 90 postoperative day period.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study never started due to administrative reasons.
  </why_stopped>
  <start_date type="Anticipated">May 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective Cohort Study</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>S. aureus reservoir detection and/or epidemiologically-related transmission event in an OR observational unit.</measure>
    <time_frame>Approximately 103 work days</time_frame>
    <description>OR reservoirs will be surveyed for S. aureus isolation and epidemiologically-relatedness assessed</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>90-day postoperative SSIs, superficial and/or deep.</measure>
    <time_frame>1.6 years</time_frame>
    <description>surveillance of wound infections, superficial and deep</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90-day HAIs (combined incidence of SSIs, respiratory, blood stream, catheter-associated urinary tract, and C. Difficile infections).</measure>
    <time_frame>1.6 years</time_frame>
    <description>Surveillance of other healthcare-associated infections (HAIs)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Bacterial Transmission</condition>
  <condition>S.Aureus Transmission</condition>
  <condition>Operating Room Exposure to S. Aureus</condition>
  <condition>90-day Postoperative Surgical Site Infections, Superficial and Deep</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control arm will be surgical care according to usual practice with usual ambient lighting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treatment arm will include surgical care according to usual practice with germicidal ambient lighting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Germicidal lighting</intervention_name>
    <description>Germicidal ambient lighting</description>
    <arm_group_label>Treatment Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult, at least 18 years old

          -  Adult patients undergoing orthopedic, cardiothoracic, gyn/onc, and neuro surgery and
             general anesthesia according to usual care with peripheral and/or central venous
             access.

        Exclusion Criteria:

          -  Pediatric (&lt;18 years old),

          -  Incarcerated, and/or

          -  Pregnant patients

          -  Undergoing surgery and/or without peripheral or central venous access.

          -  Undergoing surgery outside of the classifications above
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Randy W. Loftus, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Iowa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Loftus RW, Dexter F, Robinson ADM. High-risk Staphylococcus aureus transmission in the operating room: A call for widespread improvements in perioperative hand hygiene and patient decolonization practices. Am J Infect Control. 2018 Oct;46(10):1134-1141. doi: 10.1016/j.ajic.2018.04.211. Epub 2018 Jun 12.</citation>
    <PMID>29907449</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Dexter F, Robinson ADM. Methicillin-resistant Staphylococcus aureus has greater risk of transmission in the operating room than methicillin-sensitive S aureus. Am J Infect Control. 2018 May;46(5):520-525. doi: 10.1016/j.ajic.2017.11.002. Epub 2018 Jan 4.</citation>
    <PMID>29307750</PMID>
  </reference>
  <reference>
    <citation>Loftus RW, Dexter F, Robinson ADM, Horswill AR. Desiccation tolerance is associated with Staphylococcus aureus hypertransmissibility, resistance and infection development in the operating room. J Hosp Infect. 2018 Nov;100(3):299-308. doi: 10.1016/j.jhin.2018.06.020. Epub 2018 Jun 30.</citation>
    <PMID>29966756</PMID>
  </reference>
  <reference>
    <citation>Magill SS, O'Leary E, Janelle SJ, Thompson DL, Dumyati G, Nadle J, Wilson LE, Kainer MA, Lynfield R, Greissman S, Ray SM, Beldavs Z, Gross C, Bamberg W, Sievers M, Concannon C, Buhr N, Warnke L, Maloney M, Ocampo V, Brooks J, Oyewumi T, Sharmin S, Richards K, Rainbow J, Samper M, Hancock EB, Leaptrot D, Scalise E, Badrun F, Phelps R, Edwards JR; Emerging Infections Program Hospital Prevalence Survey Team. Changes in Prevalence of Health Care-Associated Infections in U.S. Hospitals. N Engl J Med. 2018 Nov 1;379(18):1732-1744. doi: 10.1056/NEJMoa1801550.</citation>
    <PMID>30380384</PMID>
  </reference>
  <reference>
    <citation>Koff MD, Brown JR, Marshall EJ, O'Malley AJ, Jensen JT, Heard SO, Longtine K, O'Neill M, Longtine J, Houston D, Robison C, Moulton E, Patel HM, Loftus RW. Frequency of Hand Decontamination of Intraoperative Providers and Reduction of Postoperative Healthcare-Associated Infections: A Randomized Clinical Trial of a Novel Hand Hygiene System. Infect Control Hosp Epidemiol. 2016 Aug;37(8):888-95. doi: 10.1017/ice.2016.106. Epub 2016 Jun 7.</citation>
    <PMID>27267310</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 20, 2019</study_first_submitted>
  <study_first_submitted_qc>March 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2019</study_first_posted>
  <last_update_submitted>March 3, 2020</last_update_submitted>
  <last_update_submitted_qc>March 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Iowa</investigator_affiliation>
    <investigator_full_name>Randy Loftus</investigator_full_name>
    <investigator_title>Associate Professor of Anesthesia and Critical Care Medicine</investigator_title>
  </responsible_party>
  <keyword>Germicidal lights</keyword>
  <keyword>S. aureus</keyword>
  <keyword>Transmission</keyword>
  <keyword>Operating room S. aureus exposure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Surgical Wound Infection</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD related to the registered primary (S. aureus transmission dynamics) and secondary outcomes (healthcare-associated infections) will be shared freely with scientists who request them. The request process will require submission and review of a research proposal for data use by the PI (Loftus) and Indigo-Clean.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>IPD will be available for sharing immediately after publication and ending 5 years following article publication.</ipd_time_frame>
    <ipd_access_criteria>IPD will be accessible to researchers who provide a methodologically sound proposal, to achieve aims in the approved proposal.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

